The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods Study

BACKGROUND: In the United States, people with relapsing-remitting multiple sclerosis (RRMS) can face difficulty accessing disease-modifying therapies (DMTs) because of insurance, pharmacy, or provider policies. These barriers have been associated with poor adherence and negative health outcomes. OBJ...

Descripción completa

Detalles Bibliográficos
Autores principales: Simacek, Kristina F, Ko, John J, Moreton, Debbie, Varga, Stefan, Johnson, Kristen, Katic, Bozena J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234348/
https://www.ncbi.nlm.nih.gov/pubmed/30377144
http://dx.doi.org/10.2196/11168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234348/
https://www.ncbi.nlm.nih.gov/pubmed/30377144
http://dx.doi.org/10.2196/11168

Ejemplares similares